Yahoo Finance

Vectorized Antibodies By In Vivo Expression Of DNA Or RNA Market Research 2025 | Overcoming Antibody Therapy Limitations with Vectorized Innovations

Vectorized antibodies hold promise to overcome many of these limitations and provide a great opportunity for DNA and RNA technology companies to enter larger markets compared with the rare disease ...

Armatus Announces Groundbreaking Data Supporting TVR110, a Vectorized MicroRNA Therapy for the Treatment of Charcot-Marie-Tooth Disease Type 1A

Armatus Bio, a late-preclinical stage biotech innovator developing vectorized RNAi medicines in neuromuscular disorders, today announced the publication of foundational data in Molecular Therapy ...
Healio

FDA grants fast track designation to vectorized antibody to treat ALS

Please provide your email address to receive an email when new articles are posted on . VTx-002 targets proteins that play a significant role in neurodegenerative disease. Enrollment in and ...
SiliconANGLE

Data streaming startup Vectorized raises $15.5M to take on Apache Kafka

Vectorized Inc., a new data management startup, today disclosed that it has raised $15.5 million across two funding rounds from Lightspeed Venture Partners and Alphabet Inc.’s GV fund. The startup’s ...
Yahoo Finance

VectorY Therapeutics and Shape Therapeutics Announce Option and License Agreement to Advance Vectorized Antibodies for Neurodegenerative Diseases Using an AAV5-Derived CNS Capsid

AMSTERDAM & BOSTON & SEATTLE, September 18, 2025--(BUSINESS WIRE)--VectorY Therapeutics, a biotechnology company developing innovative vectorized antibody therapies for the treatment of ...